<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Bergen, P.F.M.M. van</title>
    <link>http://repub.eur.nl/res/aut/10117/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>The cardiac infarction injury score as a predictor for long-term mortality in survivors of a myocardial infarction (Article)</title>
      <link>http://repub.eur.nl/res/pub/5569/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>AIMS: The Cardiac Infarction Injury Score (CIIS) is an electrocardiographic classification system that was developed as a diagnostic tool to assess the extent of cardiac injury in acute myocardial infarction. We investigated the prognostic value of the CIIS in post-myocardial infarction patients. METHODS AND RESULTS: The prognostic values of the CIIS for total and cardiac mortality was assessed in a large series (n = 3395) of patients who were enrolled in the ASPECT trial. Standard 12-lead electrocardiograms, recorded prior to hospital discharge were coded according to the CIIS and the Minnesota Code. Mean CIIS was 26 (range--8 to 59). After adjustment for other baseline characteristics, the CIIS was directly related to the risk of total mortality and cardiac mortality. At one-year follow-up the relative risks of CIIS &gt; or = 40, CIIS 30-40 and CIIS 20-30 were significantly higher than in those with a CIIS &lt; 20. The relative risks were, respectively, 2.3 (1.2-4.4), 2.2 (1.3-3.9) and 1.6 (0.9-2.9). At 3 year follow-up, the relative risks were, respectively, 2.1 (1.4-3.2), 1.7 (1.2-2.4) and 1.5 (1.0-2.1). The relative risks for total mortality were similar. When patients with major ECG abnormalities, as defined by the Minnesota code, were excluded, the associations were still significant in the CIIS classes 30-40 and &gt; 40. CONCLUSION: The CIIS ECG scoring system is an important predictor for long-term cardiac mortality in post myocardial infarction patients. It can easily be automated and is efficient for classifying cardiac injury in epidemiological studies.</description>
    </item> <item>
      <title>Long-term oral anticoagulant treatment after myocardial infarction : results of the 'Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis' (ASPECT) trial (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/23907/</link>
      <pubDate>1994-11-23T00:00:00Z</pubDate>
      <description>Despite the fact that mortality from cardiovascular diseases has declined considerably
over the last decades, it still represents the leading cause of mortality and
morbidity in industrialized countries. Most clinical manifestations of cardiovascular
disease share the underlying pathophysiological process of atherosclerosis.
Atherosclerosis is a diseased state of the intima and media of medium to large sized
arteries characterized by focal plaques preferentially located in areas of low shear.
It is assumed that plaques origin from fatty streaks that are initiated by oxidation of
low density lipoprotein. Formation of fatty streaks may also follow initial injury
from a wide range of agents including toxins, viral infections and intraluminal
devices such as catheters. The subsequent inflammatory reactions induce smooth
muscle proliferation by growth factor production from a wide range of cells
including platelets, endothelial cells, macrophages, and other smooth muscle cells.
The development of fatty streaks may already commence early in childhood and
progress over a period of decades to become atherosclerotic plaques which contain
lipid-filled foam cells, extracellular lipid and a layer of smooth muscle cells just
beneath the endothelium.' Plaque growth is mediated by the proliferation of smooth
muscle cells and extracellular connective tissue elements such as collagen, elastin,
and proteoglycans. Growth factors derived from the interaction between platelets
and the underlying artery wall further stimulates this process. This process will
lead to the formation of a fibrolipid plaque that constitutes a core of extracellular
lipid separated from the media by smooth muscle cells and covered and separated
from the lumen by a thick cap of collagen-rich fibrous tissue containing smooth
muscle cells. Surrounding the lipid core are lipid-filled foam cells. Elevated
coronary plaques may cause clinical symptoms when the plaque size is sufficient to
obstruct the normal bloodflow, usually when it occupies more than 40 percent of the original cross-sectional area of the lumen. As the result of a dynamic interplay
between plaque vulnerability, possibly mediated through a process of inflammation,
and external stresses the atherosclerotic plaque surface may eventually rupture.</description>
    </item>
  </channel>
</rss>